These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25899063)

  • 1. NANOG signaling promotes metastatic capability of immunoedited tumor cells.
    Lee HJ; Noh KH; Lee YH; Song KH; Oh SJ; Kim SY; Kim TW
    Clin Exp Metastasis; 2015 Jun; 32(5):429-39. PubMed ID: 25899063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanog signaling in cancer promotes stem-like phenotype and immune evasion.
    Noh KH; Kim BW; Song KH; Cho H; Lee YH; Kim JH; Chung JY; Kim JH; Hewitt SM; Seong SY; Mao CP; Wu TC; Kim TW
    J Clin Invest; 2012 Nov; 122(11):4077-93. PubMed ID: 23093782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
    J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.
    Uthaya Kumar DB; Chen CL; Liu JC; Feldman DE; Sher LS; French S; DiNorcia J; French SW; Naini BV; Junrungsee S; Agopian VG; Zarrinpar A; Machida K
    Gastroenterology; 2016 Mar; 150(3):707-19. PubMed ID: 26582088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
    Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
    BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients.
    Wang D; Lu P; Zhang H; Luo M; Zhang X; Wei X; Gao J; Zhao Z; Liu C
    Oncotarget; 2014 Nov; 5(21):10803-15. PubMed ID: 25301732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWIST1-mediated transcriptional activation of PDGFRβ in breast cancer stem cells promotes tumorigenesis and metastasis.
    Yeeravalli R; Kaushik K; Das A
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166141. PubMed ID: 33845139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Snail regulates Nanog status during the epithelial-mesenchymal transition via the Smad1/Akt/GSK3β signaling pathway in non-small-cell lung cancer.
    Liu CW; Li CH; Peng YJ; Cheng YW; Chen HW; Liao PL; Kang JJ; Yeng MH
    Oncotarget; 2014 Jun; 5(11):3880-94. PubMed ID: 25003810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells.
    Zheng Q; Banaszak L; Fracci S; Basali D; Dunlap SM; Hursting SD; Rich JN; Hjlemeland AB; Vasanji A; Berger NA; Lathia JD; Reizes O
    Endocr Relat Cancer; 2013 Dec; 20(6):797-808. PubMed ID: 24025407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling.
    Pan J; Fang S; Tian H; Zhou C; Zhao X; Tian H; He J; Shen W; Meng X; Jin X; Gong Z
    Mol Cancer; 2020 Jan; 19(1):9. PubMed ID: 31941509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
    Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
    Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Sox6 as a regulator of pancreatic cancer development.
    Jiang W; Yuan Q; Jiang Y; Huang L; Chen C; Hu G; Wan R; Wang X; Yang L
    J Cell Mol Med; 2018 Mar; 22(3):1864-1872. PubMed ID: 29369542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters.
    Li J; Zhou BP
    BMC Cancer; 2011 Feb; 11():49. PubMed ID: 21284870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection.
    Wu KJ; Yang MH
    Biosci Rep; 2011 Dec; 31(6):449-55. PubMed ID: 21919891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nkx2.8 Inhibits Epithelial-Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of
    Yu C; Liu Z; Chen Q; Li Y; Jiang L; Zhang Z; Zhou F
    Cancer Res; 2018 Mar; 78(5):1241-1252. PubMed ID: 29311157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BTF3-mediated regulation of BMI1 promotes colorectal cancer through influencing epithelial-mesenchymal transition and stem cell-like traits.
    Zhou W; Yun Z; Wang T; Li C; Zhang J
    Int J Biol Macromol; 2021 Sep; 187():800-810. PubMed ID: 34293363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.
    Avasarala S; Van Scoyk M; Karuppusamy Rathinam MK; Zerayesus S; Zhao X; Zhang W; Pergande MR; Borgia JA; DeGregori J; Port JD; Winn RA; Bikkavilli RK
    J Biol Chem; 2015 May; 290(21):13479-89. PubMed ID: 25847239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.